Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0D9RL
|
||||
Former ID |
DNC013739
|
||||
Drug Name |
(-)-eseroline
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [551355] | ||
Structure |
Download2D MOL |
||||
Formula |
C13H18N2O
|
||||
Canonical SMILES |
CC12CCN(C1N(C3=C2C=C(C=C3)O)C)C
|
||||
InChI |
1S/C13H18N2O/c1-13-6-7-14(2)12(13)15(3)11-5-4-9(16)8-10(11)13/h4-5,8,12,16H,6-7H2,1-3H3/t12-,13+/m1/s1
|
||||
InChIKey |
HKGWQUVGHPDEBZ-OLZOCXBDSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Delta-type opioid receptor | Target Info | Inhibitor | [551355] | |
Mu-type opioid receptor | Target Info | Inhibitor | [551355] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.